Pacira Pharmaceuticals Stock Today
| PCRX Stock | USD 26.81 0.71 2.72% |
Performance0 of 100
| Odds Of DistressLess than 1
|
Pacira Pharmaceuticals is trading at 26.81 as of the 24th of April 2024; that is 2.72 percent increase since the beginning of the trading day. The stock's open price was 26.1. Pacira Pharmaceuticals has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Pacira Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 3rd of February 2011 | Category Healthcare | Classification Health Care |
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida. The company has 46.5 M outstanding shares of which 3.74 M shares are at this time shorted by private and institutional investors with about 7.15 trading days to cover. More on Pacira Pharmaceuticals
Moving against Pacira Stock
| 0.65 | LLY | Eli Lilly Earnings Call This Week | PairCorr |
| 0.62 | OPT | Opthea | PairCorr |
| 0.57 | ELYM | Eliem Therapeutics | PairCorr |
| 0.57 | MRK | Merck Company Earnings Call Tomorrow | PairCorr |
| 0.52 | DYAI | Dyadic International Financial Report 8th of May 2024 | PairCorr |
| 0.47 | ERNA | Eterna Therapeutics | PairCorr |
| 0.45 | PBH | Prestige Brand Holdings Financial Report 2nd of May 2024 | PairCorr |
Pacira Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Pacira Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Pacira Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO Director | Frank Lee | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, SP Small-Cap 600, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Pacira Pharmaceuticals report their recommendations after researching Pacira Pharmaceuticals' financial statements, talking to executives and customers, or listening in on Pacira Pharmaceuticals' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Pacira Pharmaceuticals. The Pacira consensus assessment is calculated by taking the average forecast from all of the analysts covering Pacira Pharmaceuticals. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Pacira Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Pacira Pharmaceuticals is performing exceptionally good at this time. It has a great probability to report excellent financial results in May. Financial strength of Pacira Pharmaceuticals is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pacira Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Pacira Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Pacira Pharmaceuticals' financial leverage. It provides some insight into what part of Pacira Pharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pacira Pharmaceuticals (PCRX) is traded on NASDAQ Exchange in USA. It is located in 5401 West Kennedy Boulevard, Tampa, FL, United States, 33609 and employs 711 people. Pacira Pharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.21 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pacira Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Pacira Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pacira Pharmaceuticals conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 46.5 M outstanding shares of which 3.74 M shares are at this time shorted by private and institutional investors with about 7.15 trading days to cover.
Pacira Pharmaceuticals currently holds about 316.39 M in cash with 154.65 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.9.
Check Pacira Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationPacira Pharmaceuticals has a total of 46.5 Million outstanding shares. The majority of Pacira Pharmaceuticals outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Pacira Pharmaceuticals to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Pacira Pharmaceuticals. Please pay attention to any change in the institutional holdings of Pacira Pharmaceuticals as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Pacira Ownership Details
Pacira Stock Price Odds Analysis
Based on a normal probability distribution, the odds of Pacira Pharmaceuticals jumping above the current price in 90 days from now is under 95%. The Pacira Pharmaceuticals probability density function shows the probability of Pacira Pharmaceuticals stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Pacira Pharmaceuticals has a beta of 0.7997 indicating as returns on the market go up, Pacira Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Pacira Pharmaceuticals will be expected to be much smaller as well. Additionally, pacira Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Pacira Pharmaceuticals to move above the current price in 90 days from now is under 95 (This Pacira Pharmaceuticals probability density function shows the probability of Pacira Stock to fall within a particular range of prices over 90 days) .
Pacira Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Pacira Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Pacira Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Pacira Pharmaceuticals' value.| Instituion | Recorded On | Shares | |
| Rock Springs Capital Management Lp | 2023-12-31 | 1.1 M | |
| Pacer Advisors, Inc. | 2023-12-31 | 1 M | |
| Rice Hall James & Associates, Llc | 2023-12-31 | 1 M | |
| Geode Capital Management, Llc | 2023-12-31 | 1 M | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 685.3 K | |
| Schroder Investment Management Group | 2023-12-31 | 621.7 K | |
| Hhg Plc | 2023-12-31 | 604 K | |
| Gagnon Securities Llc | 2023-12-31 | 545.6 K | |
| Northern Trust Corp | 2023-12-31 | 528.3 K | |
| Blackrock Inc | 2023-12-31 | 8.1 M | |
| Vanguard Group Inc | 2023-12-31 | 5.1 M |
Pacira Pharmaceuticals Historical Income Statement
Pacira Pharmaceuticals Income Statement is one of the three primary financial statements used for reporting Pacira's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Pacira Pharmaceuticals revenue and expense. Pacira Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Pacira Pharmaceuticals' Income Tax Expense is fairly stable compared to the past year. Net Income From Continuing Ops is likely to rise to about 7.3 M in 2024, whereas Interest Expense is likely to drop slightly above 16.1 M in 2024. View More FundamentalsPacira Stock Against Markets
Picking the right benchmark for Pacira Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Pacira Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Pacira Pharmaceuticals is critical whether you are bullish or bearish towards Pacira Pharmaceuticals at a given time. Please also check how Pacira Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pacira Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Pacira Pharmaceuticals Corporate Directors
Pacira Pharmaceuticals corporate directors refer to members of a Pacira Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Pacira Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Pacira Pharmaceuticals' board members must vote for the resolution. The Pacira Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Gary Pace | Independent Director | Profile | |
| Mark Kronenfeld | Independent Director | Profile | |
| John Longenecker | Independent Director | Profile | |
| Mark Froimson | Director | Profile |
How to buy Pacira Stock?
Before investing in Pacira Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Pacira Pharmaceuticals. To buy Pacira Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Pacira Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Pacira Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Pacira Pharmaceuticals stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Pacira Pharmaceuticals stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Pacira Pharmaceuticals, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Pacira Stock please use our How to Invest in Pacira Pharmaceuticals guide.
Already Invested in Pacira Pharmaceuticals?
The danger of trading Pacira Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Pacira Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Pacira Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Pacira Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Pacira Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacira Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacira Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacira Pharmaceuticals Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacira Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Pacira Stock please use our How to Invest in Pacira Pharmaceuticals guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Pacira Stock analysis
When running Pacira Pharmaceuticals' price analysis, check to measure Pacira Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira Pharmaceuticals is operating at the current time. Most of Pacira Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pacira Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pacira Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| CEOs Directory Screen CEOs from public companies around the world |
Is Pacira Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacira Pharmaceuticals. If investors know Pacira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacira Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.291 | Earnings Share 0.89 | Revenue Per Share 14.603 | Quarterly Revenue Growth 0.054 | Return On Assets 0.0335 |
The market value of Pacira Pharmaceuticals is measured differently than its book value, which is the value of Pacira that is recorded on the company's balance sheet. Investors also form their own opinion of Pacira Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Pacira Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacira Pharmaceuticals' market value can be influenced by many factors that don't directly affect Pacira Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacira Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacira Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacira Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.